Literature DB >> 16619010

Kit and melanocyte migration.

James M Grichnik1.   

Abstract

As described in this issue, Alexeev and Yoon introduced a Kit-activating mutation into melanocytes. Although mitogenic in mast cells, this mutation was motogenic in melanocytes. Further, melanocytes had a reduced proliferative rate and were less differentiated. The disparate response may be due to differences in the cellular milieu of melanocytes and may have implications for normal melanocytic integration into the epidermis, nevogenesis, and melanoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619010     DOI: 10.1038/sj.jid.5700164

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 2.  Molecular testing in melanoma.

Authors:  Melissa Ann Wilson; Katherine L Nathanson
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

3.  Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.

Authors:  Jonathan G Bonchak; Jonathan M Eby; Kristin A Willenborg; David Chrobak; Steven W Henning; Anna Krzywiec; Steven L Johnson; I Caroline Le Poole
Journal:  Arch Biochem Biophys       Date:  2014-08-14       Impact factor: 4.013

4.  p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.

Authors:  Tamara Terzian; Enrique C Torchia; Daisy Dai; Steven E Robinson; Kazutoshi Murao; Regan A Stiegmann; Victoria Gonzalez; Glen M Boyle; Marianne B Powell; Pamela M Pollock; Guillermina Lozano; William A Robinson; Dennis R Roop; Neil F Box
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

5.  Chicken trunk neural crest migration visualized with HNK1.

Authors:  Dion Giovannone; Blanca Ortega; Michelle Reyes; Nancy El-Ghali; Maes Rabadi; Sothy Sao; Maria Elena de Bellard
Journal:  Acta Histochem       Date:  2015-03-21       Impact factor: 2.479

6.  Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.

Authors:  Carlos A Torres-Cabala; Wei-Lien Wang; Jonathan Trent; Dan Yang; Su Chen; John Galbincea; Kevin B Kim; Scott Woodman; Michael Davies; Jose A Plaza; J W Nash; Victor G Prieto; Alexander J Lazar; Doina Ivan
Journal:  Mod Pathol       Date:  2009-08-28       Impact factor: 7.842

7.  Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression.

Authors:  Keiran S M Smalley; Rooha Contractor; Thiennga K Nguyen; Min Xiao; Robin Edwards; Viswanathan Muthusamy; Alastair J King; Keith T Flaherty; Marcus Bosenberg; Meenhard Herlyn; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 8.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  In vitro dedifferentiation of melanocytes from adult epidermis.

Authors:  Bernadett Kormos; Nóra Belso; Attila Bebes; Gábor Szabad; Sarolta Bacsa; Márta Széll; Lajos Kemény; Zsuzsanna Bata-Csörgo
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

10.  A novel splicing mutation of KIT results in piebaldism and auburn hair color in a Chinese family.

Authors:  Yong-jia Yang; Rui Zhao; Xin-yu He; Li-ping Li; Ke-wei Wang; Liu Zhao; Ming Tu; Jin-song Tang; Zhi-guo Xie; Yi-min Zhu
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.